The #MedTech M&A market has demonstrated remarkable resilience despite a period of #macroeconomic uncertainty. However, the growth drivers of today look significantly different from those making waves during the pandemic era.
https://t.co/0rfioAfnRd
M&A activity in 2024 has been robust, with 195 deals announced through the third quarter, already exceeding the 128 transactions for the entirety of 2023.
https://t.co/THapgayAVJ
#medtech#InvestmentOpportunities
#MedTech continues to push at new frontiers, as ongoing breakthroughs in MedTech #AI and renewed hope for MedTech M&A hold out the possibility of making devices smarter, smaller, and more personalized.
Read the full report from @EYnews:
https://t.co/Om5pQwNFhD
#biotech#trends